-
-
-
-
-
-
-
Leerink Partners stays Outperform on Mereo BipPharma Group (MREO) despite mixed data
-
-
-
-
-
-
-
Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate HighlightsÂ
-
-
-
-
-
-
-
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights
-
-
-
-
-
-
-
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference
-
-
-
-
-
-
-
Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
-
-
-
-
-
-
-
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
-
-
-
-
-
-
-
Ultragenyx and Mereo BioPharma Announce Positive Data from the Ongoing Phase 2/3 Orbit Study of Setrusumab (UX143) in Osteogenesis Imperfecta (OI)
-
1,219,398 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

